New pain treatment tested in humans

November 27, 2017, Wiley

Nerve growth factor signals through receptors of the tropomyosin-related kinase (Trk) family, and research in animals has shown that inhibitors of Trks A, B, and C can reduce pain. Now a new study in the British Journal of Clinical Pharmacology provides the first demonstration of pain relief in humans using a Trk inhibitor.

The inhibitor was compared with pregabalin, ibuprofen, and placebo, in randomized, double blind, cross-over study with 20 participants.

"One striking aspect of this study is the use of a pain challenge model to assess this novel Trk mechanism. By determining the effect of a single dose of the drug in healthy subjects, we were able to provide an early demonstration of analgesia without the need to run a large patient study," said lead author Dr. Peter Loudon, of Pfizer WRD, in the UK.

"Furthermore, the use of a range of different pain challenge models has provided some information on the quality of effect, which may help predict the best patient population for future studies."

Explore further: Naloxegol has no effect on opioid dose in opioid-tied constipation

More information: Peter Loudon et al. Demonstration of an anti-hyperalgesic effect of a novel pan Trk inhibitor PF-06273340 in a battery of human evoked pain models., British Journal of Clinical Pharmacology (2017). DOI: 10.1111/bcp.13448

Related Stories

Naloxegol has no effect on opioid dose in opioid-tied constipation

September 21, 2017
(HealthDay)—For patients with noncancer pain and opioid-induced constipation (OIC), naloxegol has no clinically relevant effect on patient-reported pain levels or mean daily opioid dose, according to research published ...

Pregabalin benefits not linked to prior gabapentin use

September 23, 2016
(HealthDay)—Pregabalin is beneficial for neuropathic pain, regardless of previous gabapentin use, according to research published online Sept. 9 in Pain Practice.

New hope for osteoarthritis patients suffering severe pain in hands

November 13, 2017
Osteoarthritis is the most prevalent arthritis worldwide and is characterised by chronic pain and impaired physical function.

Morphine effects similar to placebo in rheumatoid arthritis

July 27, 2017
(HealthDay)—For patients with chronic fatigue syndrome (CFS)/fibromyalgia (FM) or rheumatoid arthritis (RA), morphine has anti-hyperalgesic effects comparable to placebo, according to a study published online July 19 in ...

Pregabalin significantly improves neuropathic pain

September 9, 2016
(HealthDay)—Pregabalin significantly improves neuropathic pain, irrespective of the time since pain onset, according to a study published online Sept. 2 in Pain Practice.

Evidence does not support the use of gabapentinoids for chronic low back pain

August 15, 2017
Existing evidence on the use of gabapentinoids in chronic low back pain (CLBP) is limited, and demonstrates significant risk of adverse effects with no benefits on pain relief, according to a meta-analysis published in PLOS ...

Recommended for you

Discovery opens door for synthetic opioids with less addictive qualities

June 1, 2018
Making opioids from sugar instead of from field grown opium poppies has the potential to solve many of the problems associated with manufacturing strong pain killers.

US doctors prescribing fewer opioid painkillers: report

May 31, 2018
US doctors reduced the number of prescriptions for opioid painkillers last year, continuing a five-year trend, in an effort to reverse a deadly drug abuse epidemic, a report released Thursday said.

Researchers publish study on new therapy to treat opioid use disorder

May 22, 2018
Better delivery of medications to treat opioid use disorder (OUD) is key to addressing the opioid crisis and helping the 2.6 million Americans affected by the disease.

Could nonprofit drug companies cut sky-high prices?

May 17, 2018
(HealthDay)—Generic prescription drugs should be cheap, but prices for some have soared in the United States in recent years. Now a group of U.S. hospitals thinks it has a solution: a nonprofit drug maker.

Fewer antibiotics for kids, but more ADHD drugs

May 15, 2018
(HealthDay)—American kids are taking fewer prescription medications these days—but certain drugs are being prescribed more than ever, a new government study finds.

Opioid makers' perks to docs tied to more prescriptions

May 14, 2018
Doctors who accept perks from companies that make opioid painkillers are more likely to prescribe the drugs for their patients, new research suggests.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.